首页 方达代表海森生物参与由康桥资本领投的A轮融资,涉及交易金额3.15亿美元
The press releases published in this section have been uploaded by law firms. Their content has not been appraised or edited by Law.asia, and no responsibility is taken for the accuracy of the information they contain or any misrepresentation therein. For our independent editorial content, please visit our homepage.
方达律师事务所代表海森生物参与由康桥资本领投的A轮融资,涉及交易金额3.15亿美元。该交易已于2023年3月21日交割。方达团队由合伙人李娜和许馨月牵头,团队核心成员包括李效正、徐冰彦、封浩君、谢佳欣和宋熠雯。方达处理了交易文件的起草、审阅和谈判。集研发、生产和商业推广,覆盖全产业链的海森生物由亚洲最大的专注于医疗健康行业的私募股权基金之一康桥资本、合肥产投集团与合肥市肥东县共同投资组建。
